One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood-2021-149361
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 5, 2021 |
Affiliation: Northwestern University, University of Maryland, Baltimore, Augusta University Health, Rambam Health Care Campus, Shaare Zedek Medical Center, Hackensack University Medical Center, Soroka Medical Center, NewYork–Presbyterian Hospital, Cornell University, New York Hospital Queens, Presbyterian Hospital, West Virginia University, West Virginia State University, Rabin Medical Center, The Ohio State University Wexner Medical Center, University of Pennsylvania, Baylor Scott & White Health, University of Washington, University of Virginia, University of Michigan–Ann Arbor
Aspacytarabine (BST-236) As Monotherapy Is Safe, Well-Tolerated and Effective for the Treatment of Adults with Newly Diagnosed Acute Myeloid Leukemia Unfit for Intensive Therapy. Results of a Phase 2 Study
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
